Nuron Biotech, Inc.
Industry
- Biotechnology
- Large Molecule
- Pharmaceuticals
- Vaccines
Other Names/Subsidiaries
- Pfizer Inc
Latest on Nuron Biotech, Inc.
Karolinska Development AB has appointed current deputy CEO and chief investment officer Viktor Drvota CEO, following the resignation of current CEO, Jim Van heusden . Drvota’s appointment will
Start-Up Execs Abide Therapeutics Inc. Gary O’Neill, PhD To: VP, Biology (October) From: VP, & Discovery Site Head, Merck Research Laboratories Phone: 858-427-2590 Akebia Therapeutics Inc.
Financings In the fourth quarter of 2012, start-up companies raised a total of $670.3 million across all industries, which was just $11.6 million less than in Q3. ( See Exhibit 1. ) Biopharmas brought
Financings Biopharma financing in the final quarter of 2012 reached $4.2 billion, a 36% increase over Q3’s $3.1 billion, again boosted by a strong showing from follow-on public offerings. The fourth q